Viewing Study NCT06634420


Ignite Creation Date: 2025-12-25 @ 4:24 AM
Ignite Modification Date: 2026-01-10 @ 4:16 AM
Study NCT ID: NCT06634420
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-12-18
First Post: 2024-10-07
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: HAELO: A Phase 3 Study to Evaluate NTLA-2002 in Participants With Hereditary Angioedema (HAE)
Sponsor: Intellia Therapeutics
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: ITL-2002-CL-301
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators